
Povofortay®Receives European Approval as the First Once-Daily Oral Therapy for Moderate-to-Severe Hidradenitis Suppurativa in Adults
Incyte Receives European Commission Approval for Povofortay as a Once-Daily Oral Treatment for Moderate to Severe Hidradenitis Suppurativa Incyte has announced that the European Commission (EC) has approved Povofortay® (povorcitinib)…













